39 phenotypes from 2 alleles in 2 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Hgsnatem4(IMPC)Tcp/Hgsnatem4(IMPC)Tcp C57BL/6NCrl-Hgsnatem4(IMPC)Tcp/Tcp	abnormal cholesterol homeostasis	J:211773
	abnormal lung morphology	J:211773
	decreased exploration in new environment	J:211773
	decreased total body fat amount	J:211773
	enlarged lymph nodes	J:211773
	enlarged urinary bladder	J:211773
	increased bone mineral content	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased circulating phosphate level	J:211773
	increased circulating potassium level	J:211773
	increased lean body mass	J:211773
	increased startle reflex	J:211773
	short tibia	J:211773
Hgsnattm1a(EUCOMM)Wtsi/Hgsnattm1a(EUCOMM)Wtsi involves: C57BL/6N * C57BL/6NTac	abnormal bronchus epithelium morphology	J:235361
	abnormal cerebral cortex morphology	J:235361
	abnormal CNS glial cell morphology	J:235361
	abnormal enzyme/coenzyme activity	J:235361
	abnormal glycosaminoglycan level	J:235361
	abnormal hepatocyte morphology	J:235361
	abnormal Kupffer cell morphology	J:235361
	abnormal lysosome morphology	J:235361
	abnormal mitochondrial crista morphology	J:235361
	abnormal nervous system morphology	J:235361
	abnormal neuron mitochondrial morphology	J:235361
	abnormal proximal convoluted tubule morphology	J:235361
	abnormal Purkinje cell mitochondrial morphology	J:235361
	abnormal Purkinje cell morphology	J:235361
	abnormal ventricle myocardium morphology	J:235361
	astrocytosis	J:235361
	decreased locomotor activity	J:235361
	enlarged liver	J:235361
	enlarged spleen	J:235361
	increased anxiety-related response	J:235361
	increased blood urea nitrogen level	J:235361
	increased circulating alanine transaminase level	J:235361
	increased liver weight	J:235361
	increased spleen weight	J:235361
	microgliosis	J:235361
	premature death	J:235361